Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Astrazeneca Plc (NY: AZN)
54.19 USD  +0.72 (+1.35%)
Official Closing Price  /  Updated: 7:55 PM EDT, Jul 8, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 6,247,700
Open 53.71
Bid (Size) 54.19 (1)
Ask (Size) 54.35 (1)
Prev. Close 53.47
Today's Range 53.62 - 54.70
52wk Range 36.15 - 57.44
Shares Outstanding 2,533,294,824
Dividend Yield 2.53%
Performance
YTD
+7.54%
+7.54%
1 Month
+3.06%
+3.06%
3 Month
+23.58%
+23.58%
6 Month
+8.49%
+8.49%
1 Year
+33.01%
+33.01%
Top News
More News
Novavax's Vaccine Just Scored $1.6 Billion From Operation Warp Speed. Here's What It Means for Investors.
With late-stage clinical development costs covered by the government's funds, Novavax is cleared for takeoff. Read More
category Market News , AZN , NVAX
from Motley Fool
Revisiting Coronavirus Vaccine Timelines: Moderna Denies Delay, Pfizer Advances Project Lightspeed And More
Shares ofModerna Inc (NASDAQ: MRNA), afrontrunner in the race for a coronavirus vaccine,tumbled Thursday afternoon ... Read More
category Trading Ideas , AZN , Coronavirus , and 13 more.
from Benzinga
More News
Read More
3 Reasons You Shouldn't Get Your Hopes Too High About COVID-19 Vaccines
category MRNA , AZN , Market News
from Motley Fool
Is There a Coronavirus Vaccine Yet?
category AZN , INO , NVAX , and 3 more.
from Motley Fool
Fauci warns that COVID-19 vaccine protection may be ‘finite’
category AZN , Pharmaceuticals , General , and 4 more.
from MarketWatch
Moderna’s COVID-19 Trial Delayed: Should Investors Worry?
category MRNA , AZN , NVAX , and 1 more.
from Motley Fool
CanSino's COVID-19 Vaccine Was Just Approved for Limited Use in China. Here's What Investors Should Know.
category 6185 , Market News , MRK , and 2 more.
from Motley Fool
Best & Worst ADRs - Monday, July 6
category Stocks / Equities
from Blogs - TalkMarkets
Biotech ETFs To Gain As Coronavirus Vaccine Hopes Strengthen
category Pharma/Biotech , Stocks / Equities , ETFs
from Blogs - TalkMarkets
Is This Under-the-Radar Stock a Better Coronavirus Play Than Moderna?
category CTLT , Market News , MRNA , and 4 more.
from Motley Fool
Could Moderna Be a Millionaire-Maker Stock?
category Market News , MRNA , AZN
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.